OR WAIT null SECS
June 24, 2016
The agency recommends Zalmoxis, a new cell-based therapy to support stem cell transplantation in patients with high-risk blood cancer.
June 21, 2016
A research team associated with Dr. Carl June announces it has discovered a way to engineer a patient’s own immune cells to recognize cancer-specific glycoantigens on tumor cells.
June 16, 2016
A new indication for Emergent BioSolutions’ BioThrax will give the drug market exclusivity through November 2022.
Pfizer broke ground at its Andover, Massachusetts campus on a clinical manufacturing facility for complex biologics and vaccines.
June 15, 2016
A study published in BMJ indicates that rheumatic patients with anti-infliximab antibodies may have a similar cross reaction to infliximab biosimilars.
June 10, 2016
Alvotech prepares for commercial biosimilar production in new facility with single-use bioreactors in Reykjavik, Iceland.
June 02, 2016
Industry experts discuss the benefits and challenges of using single-use systems in pharmaceutical manufacturing.
With technology advances, continuous manufacturing shows steady progress to more widespread adoption.
June 01, 2016
More efforts are needed to raise awareness of biosimilars among physicians and patients in Europe and address scepticisms about the quality and safety of biosimilars.
May 19, 2016
A new study in Nature Communications explores how to remove the bulk of the soaps that are added to injectables to make hydrophobic drugs more soluble.